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CONCLUSIONS
•  There was 100% concordance between MEP and CSF culture for  
E. coli meningitis. 
•  The increased sensitivity of MEP may play a role in the management 
of partially treated meningitis. 
•  The use of the BioFire MEP may be helpful in decreasing the average 
LOS in patients where a viral etiology other than HSV is identified. 
•  Early identification of a pathogen other than HSV may decrease the 
number of acyclovir doses received.
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BACKGROUND
•  Cerebrospinal fluid (CSF) culture is 
the gold standard for diagnosis of 
bacterial meningitis, but results can 
take 48–72 hours.
•  Patients remain hospitalized and 
receive antimicrobial therapy while 
awaiting results of CSF cultures.
•  BioFire FilmArray™ Meningitis/
Encephalitis panel (MEP) tests CSF 
for 14 bacterial, viral and fungal 
pathogens with turnaround time  
of 1 hour. 
•  The objective of the study was to 
compare the results of MEP to 
bacterial CSF cultures and potential 
impact on length of stay and 
antimicrobial use. 
METHODS
•  Retrospective review of data from 
MEP processed by Health Network 
Laboratories.
•  Children 0–18 years of age from 
Feb. 1, 2016 to Dec. 31, 2017 at 
Lehigh Valley Children’s Hospital. 
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RESULTS
DISTRIBUTION OF PATHOGENS IN POSITIVE MEP
Figure 1. Distribution of pathogens in positive MEP.
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Figure 2. Comparison of average length of stay for all samples, including MEP and cultures, with average length 
of stay for patients with positive MEP for viral pathogens other than HSV. 
Turn around Time (hours) MEP CSF Culture
Average TAT for all samples 6.9 48.8
Max TAT for all samples 46 80
Min TAT for all samples 4 20
Average TAT for Positive samples 6.2 48.2
Average TAT for Negative samples 7.1 48.9
Table 1. Turnaround time in hours for MEP and CSF cultures.
Acyclovir Doses Received in Patients with Presumed HSV infection
No. of patients Avg. doses received
Total Patients receiving Acyclovir 58 6.3
Patients with Positive MEP for HSV  3 64
Patients with Negative MEP 37 3.1
Patients with Positive MEP other than HSV 18 1.4
Table 2. Acyclovir doses received in patients with presumed HSV infection. 
